An open-label, randomize, two-period, crossover study in healthy volunteers. Over 90% of volunteers were enrolled during the first two weeks. The target enrollment rates were reached within 21 days.
© 2020 – 2021 OCT Group LLC.
Clinical Trials in Eastern Europe, Russia, Ukraine, Georgia, Bulgaria, Latvia, Estonia, Lithuania, Belarus, Moldova, Serbia, Croatia, The Netherlands, Kazakhstan.